tion before use. Deaggregated HGG (deHGG) was prepared according to the method of Basten et al. (7) . DNP~HGG and DNPIsFGG were prepared as described previously (8) .
Sensitization Procedures. For the production of high levels of DTH, mice were treated with 200 mg/kg of cyclophosphamide (Endoxan, Asta; Mead Johnson, Crows Nest, Australia) (9) subcutaneously 2 days before giving 400/~g of FGG (in 0.1 ml) emulsified in complete Freund's adjuvant (CFA) (Difco Laboratories, Detroit, Mich. ) into the two hind foot pads and subcutaneously into the abdomen. Mice were primed to HGG by injecting 500 ~g alum-precipitated antigen (10) intraperitoneally with 2 × 109 Bordetella pertussis organisms (Pertuesis vaccine, 4 × 10 TM organisms/ml; CSL). In the case of dinitrophenylated antigens, 100 ~g DNP-HGG or 30/zg DNP-FGG was given in the soluble form intraperitoneally, l0 s HRBC were injected intravenously into each mouse. Mice were tolerized to HGG by the intravenous injection of 2.5 mg of deHGG (7) .
Cell Suspensions. Lymph nodes were removed and cell suspensions prepared by teasing organs through a stainless steel wire mesh into Eisen's balanced salt solution. They were washed three times, counted, and their viability estimated by an eosin-dye exclusion method.
DTHAssay. This is described in detail elsewhere (11) . Briefly this assay measures the influx of cells labeled with 125I-5-iodo-2'-deoxyuridine (125I-UdR) into DTH lesions. Conventionally, antigen is deposited into the left (L) pinna and the right (R) remains uninjected. 24 h later the ears are cut off and the ratio of the radioactivity in the L/R ears reflects the extent of DTH. To increase labeling efficiency 10 -7 moi of 5-fluorodeoxyuridine is injected intraperitoneally 20 min before 125I-UdR.
Assay for Plaque-Forming Cells (PFC's). PFC's were assayed by the technique of Cunningham
and Szenberg (12) . Indirect (IgG) PFC's were developed by the addition of rabbit-antimouse immunoglobulin serum to the cell mixture. This antiserum did not suppress direct (IgM) PFC's.
Cytotoxicity Assay. This method has been described in detail by Burton et al. (13) . Briefly responder spleen cells are cultured in vitro with irradiated stimulator cells for 6 days. The cells are harvested and added to target cells labeled with 5~Cr. The release of 51Cr into the supernate after a period of time is proportional to the number of cytotoxic lymphocytes added, and to the number of target cells lysed. Percent specific lysis is calculated by the formula: 51Cr release in experiment -background × 100; maximal releasable ~Cr -background where background is the release of 51Cr from target cells in the absence of immune lymphocytes and maximal releasable 51Cr is the amount released when labeled target cells are lysod with detergent.
Radioisotopes and Radiometry. 125I-UdR, sp act 90-110 ~Ci/~g, 5~Cr (sodium chromate, sp act 50-200 ~Ci/~g CEA, Gif-Sur-Yvette, France) was used as described before (13) .
Production of Antisera
ANTI-Ly-I.I, ANTI*Ly*2.1 AND ANTI-Ia l, 2, 3, 7. Thymus cells (1 donor per 10 recipients) were used for immunization for the Ly antisera, and thymus, lymph node, and spleen cells for the Ia antisera. Intraperitoneal injections were given weekly for 6-8 wk and thereafter every 2 wk. In the weeks between immunizations, the mice were bled and the sera collected and pooled. Sera were absorbed by mixing them with thymocytes (10 thymuses/ml serum) for 30 min at 4°C in order to remove autoantibody. The strains and sources of the mice used for the production and absorption of these sera are shown in Table I. ANTI-Ly-I.2 AND 2.2. These sera were prepared by Dr. Shen as described in reference 14. ANTI-Thy-1 SERUM. This was raised in AKR/J mice as described previously (15) . COMPLEMENT (C). Rabbits were bled, their serum separated and tested for C activity. Batches were selected for low cytotoxicity against mouse thymocytes and high C activity. When necessary the serum was absorbed with mouse thymocytes before use.
Treatment of Cells with Antisera
ANTI-Ly-I.1 AND 2.1 AND ANTI-Ia. To 1 ml of cells at a concentration of 1.5 x 10S/ml, 1 ml of antiserum was added to a final concentration of 1:10 for anti-Ly-l.l,l:4 for anti Ly-2.1, and 1:100 for anti-Ia, and the cells left at room temperature for 30 min, washed twice, and resuspended in rabbit C at a final concentration of 5 x 10S/ml. They were then incubated for 30 rain at 37°C and washed three times before use. The concentrations of sera used were those which lysed the maximum number of cells as determined by previous cytotexic assays.
ANTI-Ly-I.2, 2.2. Anti-Ly-l.2, 2.2 is described in detail elsewhere (14) . ANTI-Thy-1. Anti-Thy-1 was used as previously described (15) .
Specificity ofLy Antisera. The Ly antisera were raised between strains of mice congenic for the Ly-1 and Ly-2 loci (Table I ) and should contain no additional specificities other than autoantibody. This appeared to be the case as both sera reacted as expected: cells from CBA, C3H, DBA/1, and DBA/2 strains and the appropriate donors were positive when reacted with both antisera; C57BL/6, A, BALB/c, and 129 were negative. Table II . Incubation with C alone, anti-Ia serum and C, or anti-Ly-2.1 serum and C did not decrease the ability of the cells to transfer DTH, whereas anti-Ly-l.1 serum and C abolished it. The enhanced capacity of anti-Ly-2.1 serum-treated cells to transfer DTH (Table II) was observed in three out of six such experiments.
Results

Effect of Anti-Ly and Anti-Ia Sera on the Transfer of DTH by Lymph Node
To check if anti-Ly-l.2 and anti-Ly-2.2 sera had similar effects we immunized C57BL mice with FGG as described above and treated the lymph node cells Table III . Again anti~Ly-l.2 serum but not anti-Ly-2.2 serum inhibited the transfer of DTH.
These results suggest that the Ly phenotype of T, cells is the same as that reported for TH (1, 2, 5) . They do, however, differ in their sensitivity to anti-Ia serum (see below). We have previously found that lymph node cells from animals sensitized to give maximal DTH can also exert helper functions. Thus it was possible for us to compare directly the effect of antiserum treatment on the same population of lymph node cells that had the potential to transfer these two T-cell functions.
Effect of Anti-Ly and Anti.Ia Sera on the Helper Activity of Sensitized Lymph
Node Cells. Lymph node cells were taken from the same CBA animals that were used for DTH experiments. Aliquots of l0 T viable cells were treated in the following ways: (a) anti-Ly-l.1 serum and C; (b) anti-Ly-2.1 serum and C; (c) anti-Ia serum and C; (d) C alone; and (e) no treatment. Each aliquot was then transferred into six syngeneic, lethally irradiated mice together with l0 s HRBC and 5 × l0 s anti-Thy-1 serum-treated spleen cells from CBA mice primed with DNP-polymerized flagellin (POL) 2 mo previously. The animals were given 30 ~g of DNP-FGG intraperitoneally, and 7 days later the spleens were taken and assayed for anti-HRBC PFC and anti-DNP PFC (as DNP-Fab-SRBC). The results are shown in Table IV . Treatment with anti-Ly-l.1 serum and anti-Ia serum but not with anti-Ly-2.1 serum markedly inhibited the helper activity of these cells in terms of anti-DNP antibody production to DNP-FGG. Before firm conclusions could be reached about the Ly and Ia phenotypes of T, and TH cells, it was important to demonstrate that our anti-Ly-1.1 serum did not delete all T-cell functions, and that our anti-Ly-2.1 and anti-Ia sera were indeed effective against some T-cell functions. These experiments are described below. Table V . AntiThy-1 serum and C reduced this activity to 6%. Anti-Ly-2.1 serum and C and anti-Ly-1.1 serum and C reduced the cytotoxicity, but the reduction was more marked with anti-Ly-2.1 serum and C (16 vs. 26%). When BALB/c cytotoxic lymphocytes were treated in an identical manner there was no evidence of abrogation of cytotoxic activity with anti-Ly-1.1 and anti-Ly-2.1 sera (data not shown).
Effect of Anti-Ly
Effect of Anti-Ly and Anti-Ia Sera on the Suppressor Activity of Spleen Cells from HGG-Tolerant
Mice. Spleen cells taken from CBA mice injected 14 days previously with 2.5 mg of deHGG provide a source of T-cell-dependent suppressor cells (7) . When these cells were mixed with HGG-primed spleen cells and DNP-primed B cells and given to lethally irradiated syngeneic recipients challenged with DNP-HGG and HRBC, specific suppression can be demonstrated (see groups 1-4 in Table VI and reference 7) . Groups 5-8 in Table VI show the effect of the treatment of the suppressor population with Ly and Ia antisera. Groups 9-12 show the PFC's resulting when the same antisera were used on the HGG-primed population. Three points can be made about the results obtained. Anti-Ia serum was effective in diminishing the suppressive effect of HGGtolerant cells (group 7) but not the helper activity of HGG-primed cells (group 11). Anti-Ly-l.1 serum, in spite of its powerful capacity to abolish the helper activity of HGG-primed cells (group 9), had no significant effect on the suppressors (group 5). Anti-Ly-2.1 serum treatment partially removed the suppressor effect (group 6), while helper function was left intact (group 10). Suppressor cells induced in vivo in this system can therefore be characterized as Ly-l-, probably Ly-2 + and Ia +.
Discussion
Ly antisera have been very useful in characterizing the subsets of T cells required for helper (TH) and cytotoxic (Tc) functions. When CBA lymph node cells were treated with anti-Ly-l.1 serum and C their ability to transfer DTH was abolished. Anti-Ly-2.1 serum and C did not however affect this function. The phenotype of TD cells is therefore Ly-1 +,2-. It was important to demonstrate that the anti-Ly-1 serum did not ablate all T-cell functions and, as a corollary, that anti-Ly-2.1 serum was effective against other T-cell types. This was done in two different ways. When cytotoxic cells were treated with antisera, anti-Ly-1.1 serum had only a mild effect, and anti-Ly-2.1 serum a stronger inhibitory effect (Table V) . Similarly the suppressor effect of HGG-tolerant spleen cells was unaffected by anti-Ly-l.1 serum, but was partially inhibited by anti-Ly-2.1 serum.
Although the Ly-1.1 and 2.1 antisera were raised in congenic mice, and were always absorbed for autoantibody, their specificity for the appropriate allele was demonstrated in two ways. Firstly, when these sera were tested against BALB/c cytotoxic cells, there was no killing or diminution of function. Secondly, when the sera were absorbed with thymus cells from C57BL Ly congenic mice the appropriate anti-Ly activity was removed.
In order to make a general statement about the Ly phenotype of T, cells we tested the effect of anti-Ly-l.2 and anti-Ly-2.2 sera on sensitized C57BL cells. In this system T, cells were also Ly-l+,2 -. This serum was raised by Shen et al. in the Memorial-Sloan Kettering Cancer Center, New York, and was confirmed to be specific for the allele in question (14) . We have provided evidence that Ly antisera are useful in characterizing functional subsets of CBA T cells and that effector cells mediating DTH in CBA mice have Ly-l÷,2 -phenotypes. This is the same Ly phenotype which we and others (1, 2, 5) have found on TH cells. There is other evidence for similarity between the TD and TH cells. Cells taken from mice which were pretreated with cyclophosphamide and immunized with FGG in CFA in order to exhibit maximal DTH, were as powerful helpers as cells taken from mice immunized with FGG in CFA only, which exhibit very weak or no DTH. In addition, the cells responsible for helper and DTH function, although easily separable from other lymphoid cells by sedimentation velocity, 2 cannot be separated from one another by this method. There are, however, several apparent differences between T, and TM cells. For example, using simple immunization regimes there is an inverse relationship between the ability of some antigens to immunize mice to generate helper cell function or DTH (16) . Similarly these cells are different in their susceptibility to tolerogenesis (17) . These differences may reflect functional restrictions affecting identical cells (e.g., an inhibition of rapid local antigen recognition). Alternatively, these cells may in fact belong to distinct subsets.
Ia antigens, although most densely represented on B cells (18) , have been detected in small quantities on some T cells (19) (20) (21) . Despite this meager representation, treatment with anti-Ia serum and C has been shown to inhibit certain T-cell functions. The Ts cell responsible for allotype suppression (3) and in some instances the TH cell (3) have been inhibited by anti-Ia sera and C. These findings suggested that Ia antisera, like Ly, may be helpful in defining Tcell subsets. Our results confirmed the sensitivity of suppressor cells to Ia antisera with a different system. The suppressor activity in this system depends on two cell types: one, anti-Thy-1 sensitive; the other retained by an anti-Ig column (7) . When these two populations of cells are mixed the suppressor activity is restored (7). Anti-Ia treatment of the purified T cells (tolerant spleen cells passed through an anti-Ig column) abolishes their ability to restore suppressor activity to the mixture (J. R. Gamble, M. A. Vadas, J. F. A. P. Miller, and A. Basten, unpublished observation). Thus it seems that Ts cells are Ia ÷. TH cells could also be inhibited by anti-Ia serum, but only when limiting numbers of recently primed helper cells from cyclophosphamide-pretreated mice were used (Tables IV and VI (25) . Cells activated to FGG in a similar manner have in our hands repeatedly failed to initiate DTH responses. This may imply that the surfaces of such cells are blocked by Ia-antigen complexes (e.g., GRF). The cells would thus be unable to recognize antigen in a site where this was deposited to elicit DTH.
Summary
The Ly and Ia phenotypes of T lymphocytes involved in different functions were characterized by the use of specific antisera. T cells responsible for delayedtype hypersensitivity (DTH) and for helper functions were found to be Ly-l+,2 -in contrast to cytotoxic T cells and T cells responsible for suppression of antibody responses which were Ly-l-,2 ÷. Unlike some primed helper cells, T cells involved in DTH were Ia-. Suppressor cells in the system studied were Ia ÷.
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